Cargando…

Therapeutic inhibition of tumour necrosis factor alpha reduces oligoclonality in the selected T-cell receptor BV families in rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	Pierer, M, Wagner, U, Kaltenhäuser, S, Arnold, S, Häntzschel, H
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833922/ http://dx.doi.org/10.1186/ar932

Ejemplares similares

T cell contact-mediated induction of tumor necrosis factor alpha in peripheral blood monocytes is inhibited by autologous serum in rheumatoid arthritis
por: Wagner, U, et al.
Publicado: (2003)

Differences in B cell regulation in DRB1 shared epitope positive and negative rheumatoid arthritis
por: Wagner, U, et al.
Publicado: (2001)

B lymphocytopenia in rheumatoid arthritis is associated with the DRB1 shared epitope and increased acute phase response
por: Wagner, Ulf, et al.
Publicado: (2002)

Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients
por: Pierer, Matthias, et al.
Publicado: (2006)

Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
por: Cavazzana, I, et al.
Publicado: (2005)

The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
por: Mullan, RH, et al.
Publicado: (2005)

Immunogenetic Aspects of Disease Progression in Rheumatoid Arthritis
por: Wassmuth, Ralf, et al.
Publicado: (2000)

Inhibition of tumour necrosis factor alpha production by activated T cells of rheumatoid arthritis patients by novel anti-folate drugs: an ex vivo pilot study
por: van der Heijden, JW, et al.
Publicado: (2005)

The contact-mediated response of peripheral-blood monocytes to preactivated T cells is suppressed by serum factors in rheumatoid arthritis
por: Rossol, Manuela, et al.
Publicado: (2005)

Skewed T-cell receptor BV14 and BV16 expression, and shared complementarity-determining region 3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritis
por: Sun, W, et al.
Publicado: (2003)

Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
por: Balandraud, N, et al.
Publicado: (2005)

Microarray analysis for molecular characterization of disease activity and measuring outcomes of anti-tumour necrosis factor therapy in rheumatoid arthritis
por: Stuhlmüller, B, et al.
Publicado: (2005)

Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis
por: Schmeling, H, et al.
Publicado: (2008)

Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2005)

Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
por: Bayraktar, S, et al.
Publicado: (2008)

Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients
por: Coulthard, LR, et al.
Publicado: (2007)

Opioid receptor expression on neutrophils: effect of tumour necrosis factor alpha treatment
por: Schmidt, A, et al.
Publicado: (2007)

Resistance of rheumatoid arthritis synovial fibroblasts to p38 MAP-kinase inhibition of pro-destructive functions mediated by tumor necrosis factor alpha/tumor necrosis factor receptor-1
por: Kunisch, E, et al.
Publicado: (2005)

Influence of variants of Fcg receptor IIA on the European league against rheumatism responses to anti-tumour necrosis factor alpha therapy in psoriatic arthritis
por: Ramirez, J, et al.
Publicado: (2010)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

Tumor necrosis factor alpha reverses the immunosuppressive properties of mesenchymal stem cells in collagen-induced arthritis
por: Djouad, F, et al.
Publicado: (2005)

Tumour necrosis factor-α levels are elevated in adolescent patients with juvenile idiopathic arthritis on etanercept therapy
por: Radziszewska, Anna, et al.
Publicado: (2014)

Tumour necrosis factor-dependent inflammatory cartilage destruction
por: Korb, A, et al.
Publicado: (2007)

Long-term exposure of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor alpha inhibits FasL-mediated apoptosis through activation of NF-κB and upregulation of the small ubiquitin-like modifier SUMO-1
por: Pap, T, et al.
Publicado: (2004)

The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)

Significance of fatigue in patients with rheumatoid arthritis
por: Singh, G, et al.
Publicado: (2003)

Serum tumor necrosis factor alpha increased during remission with Etanercept
por: Spirchez, Mihaela, et al.
Publicado: (2011)

Diagnosis of tuberculosis infection in pediatric patients treated with inhibitors of the tumour necrosis factor alpha. A multicenter national study comparing tuberculin skin test and igra tests
por: Julian, Antoni Noguera, et al.
Publicado: (2014)

Comparison of the nodule and synovial lesions of rheumatoid arthritis
por: Highton, J, et al.
Publicado: (2003)

Collagenous colitis and rheumatoid arthritis: is there a connection?
por: Wollheim, F, et al.
Publicado: (2003)

IL-15 and its role in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2003)

The importance of cell surface RANKL in rheumatoid arthritis
por: Krystufkova, O, et al.
Publicado: (2005)

The functions of the post-translational modifications in rheumatoid arthritis
por: Aratani, Satoko, et al.
Publicado: (2012)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Circulating levels of IL-7 in rheumatoid arthritis
por: Churchman, S, et al.
Publicado: (2007)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis.
por: Fröde, Tânia Silvia, et al.
Publicado: (2002)

Living with Tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS)
por: Dandekar, P, et al.
Publicado: (2015)

Induced myelopathy after long-term anti-tumor necrosis factor alpha treatment
por: Modesto, C, et al.
Publicado: (2011)

The inhibitor of differentiation-2 promotes synovial fibroblast-dependent osteoclastogenesis in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_8cqlotp42bt86u5js1840qg3cn